Lilly's Mounjaro helps improve blood sugar control in children in late-stage trial

Core Insights - Eli Lilly's Mounjaro has shown effectiveness in helping children and adolescents aged 10 to 17 years with type 2 diabetes manage their blood sugar levels and achieve weight loss according to trial results presented at a medical meeting [1] Group 1 - Mounjaro demonstrated positive outcomes in blood sugar management for the target age group [1] - The trial results indicate significant weight loss among participants using Mounjaro [1]